Characteristic | Total n = 149 | ILD SLTx n = 34 | non-ILD SLTx n = 54 | p-value |
---|---|---|---|---|
Age, years (IQR) | 46 (36–53) | 53 (44–59) | 47 (42–52) | 0.055 |
Sex male, n (%) | 63 (42.3) | 23 (67.7) | 12 (22.2) | < 0.001 |
BMI, kg/m2 (IQR) | 18.2 (16.1–21.7) | 22.2 (18.7–25.4) | 17.7 (15.2–20.7) | < 0.001 |
LTx indication, n (%) | Â | Â | Â | N/A |
 - Fibrosis | 42 (28.2) | 34 (100) | 0 |  |
 - Obstructive | 55 (36.9) | 0 | 46 (85.2) |  |
 - Vascular | 30 (20.1) | 0 | 0 |  |
 - Suppurative | 14 (9.4) | 0 | 0 |  |
 - Allogenic | 8 (5.4) | 0 | 8 (14.8) |  |
Right-side SLTx, n (%) | 44 (29.5) | 13 (38.2) | 31 (57.4) | 0.125 |
Ischemic time, min (IQR) | 498 (436–652) | 449 (392–497) | 457 (427–500) | 0.324 |
Mechanical ventilation, day (IQR) | 10 (3–26) | 4 (2–13) | 4 (2–12) | 0.569 |
Volume reduction, n (%) | 28 (18.8) | 2 (5.9) | 2 (3.7) | 0.638 |
Delayed chest closure, n (%) | 40 (26.9) | 1 (2.9) | 3 (5.56) | 0.999 |
Tracheostomy, n (%) | 67 (45.0) | 8 (23.5) | 13 (24.1) | 0.999 |
ICU stay, day (IQR) | 16 (8–33) | 9 (6–19) | 10 (6–20) | 0.658 |
Three-month mortality, n (%) | 10 (6.7) | 1 (3.9) | 2 (3.7) | 0.999 |